A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)
Prabhat Kumar Agrawal(Sarojini Naidu Medical College), Ruchika Garg(Sarojini Naidu Medical College), Bharat Saboo(ORCID), Amit Varshney(Noida International University), Harish Kumar. B(Bangalore Diabetes Centre), Sandeep Suri(ORCID), Amitabh Biswas(All India Institute of Medical Sciences), Aravinda Jagadeesha(Bangalore Diabetes Centre), Abhisekh Raha(ORCID), Soumyaranjan Mohanty(Diabetes Care and Research Foundation), Prabhakar Damodar Gokhale(ORCID), Prahlad Chawla(ORCID), Ketan K Mehta(ORCID), Kiran Sharadchandra Shah(Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals), Sonika Lamba(Government Medical College), Kumar Prafull Chandra(ORCID), Ashish Gautam(Sarojini Naidu Medical College), Sher Singh Dariya(Diabetes Care and Research Foundation)
Cited by 1
Related Papers
RSSDI guidelines for management of type 2 diabetes mellitus in older adults
|International Journal of Diabetes in Developing Countries|2026|1
RSSDI clinical practice guidelines for the management of hyperglycemia in hospitalized patients (2025)
|International Journal of Diabetes in Developing Countries|2026|0